ID   NLGN2_RAT               Reviewed;         836 AA.
AC   Q62888;
DT   23-MAY-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-OCT-2024, entry version 165.
DE   RecName: Full=Neuroligin-2;
DE   Flags: Precursor;
GN   Name=Nlgn2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), PROTEIN SEQUENCE OF
RP   N-TERMINUS, TISSUE SPECIFICITY, AND INTERACTION WITH NEUREXIN 1-BETA;
RP   NEUREXIN 2-BETA AND NEUREXIN 3-BETA.
RC   TISSUE=Forebrain;
RX   PubMed=8576240; DOI=10.1074/jbc.271.5.2676;
RA   Ichtchenko K., Nguyen T., Suedhof T.C.;
RT   "Structures, alternative splicing, and neurexin binding of multiple
RT   neuroligins.";
RL   J. Biol. Chem. 271:2676-2682(1996).
RN   [2]
RP   INTERACTION WITH PATJ.
RX   PubMed=9647694; DOI=10.1006/mcne.1998.0679;
RA   Kurschner C., Mermelstein P.G., Holden W.T., Surmeier D.J.;
RT   "CIPP, a novel multivalent PDZ domain protein, selectively interacts with
RT   Kir4.0 family members, NMDA receptor subunits, neurexins, and
RT   neuroligins.";
RL   Mol. Cell. Neurosci. 11:161-172(1998).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=11329178; DOI=10.1002/glia.1050;
RA   Gilbert M., Smith J., Roskams A.J., Auld V.J.;
RT   "Neuroligin 3 is a vertebrate gliotactin expressed in the olfactory
RT   ensheathing glia, a growth-promoting class of macroglia.";
RL   Glia 34:151-164(2001).
RN   [4]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15620359; DOI=10.1016/j.cell.2004.11.035;
RA   Graf E.R., Zhang X., Jin S.X., Linhoff M.W., Craig A.M.;
RT   "Neurexins induce differentiation of GABA and glutamate postsynaptic
RT   specializations via neuroligins.";
RL   Cell 119:1013-1026(2004).
RN   [5]
RP   TISSUE SPECIFICITY, AND ALTERNATIVE SPLICING.
RX   PubMed=18755801; DOI=10.1210/en.2008-0274;
RA   Suckow A.T., Comoletti D., Waldrop M.A., Mosedale M., Egodage S.,
RA   Taylor P., Chessler S.D.;
RT   "Expression of neurexin, neuroligin, and their cytoplasmic binding partners
RT   in the pancreatic beta-cells and the involvement of neuroligin in insulin
RT   secretion.";
RL   Endocrinology 149:6006-6017(2008).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=18434543; DOI=10.1073/pnas.0801383105;
RA   Bolliger M.F., Pei J., Maxeiner S., Boucard A.A., Grishin N.V.,
RA   Sudhof T.C.;
RT   "Unusually rapid evolution of neuroligin-4 in mice.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:6421-6426(2008).
RN   [7]
RP   INTERACTION WITH NRXN1.
RX   PubMed=18334216; DOI=10.1016/j.str.2007.12.024;
RA   Koehnke J., Jin X., Trbovic N., Katsamba P.S., Brasch J., Ahlsen G.,
RA   Scheiffele P., Honig B., Palmer A.G. III, Shapiro L.;
RT   "Crystal structures of beta-neurexin 1 and beta-neurexin 2 ectodomains and
RT   dynamics of splice insertion sequence 4.";
RL   Structure 16:410-421(2008).
RN   [8]
RP   FUNCTION, INTERACTION WITH GPHN, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   AND MUTAGENESIS OF TYR-770.
RX   PubMed=19755106; DOI=10.1016/j.neuron.2009.08.023;
RA   Poulopoulos A., Aramuni G., Meyer G., Soykan T., Hoon M., Papadopoulos T.,
RA   Zhang M., Paarmann I., Fuchs C., Harvey K., Jedlicka P., Schwarzacher S.W.,
RA   Betz H., Harvey R.J., Brose N., Zhang W., Varoqueaux F.;
RT   "Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory
RT   synapses through gephyrin and collybistin.";
RL   Neuron 63:628-642(2009).
RN   [9]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=19859968; DOI=10.1002/jnr.22258;
RA   Lui L., Levinson J.N., Noel G., Handrigan G.R., Richman J.M.,
RA   El-Husseini A., Moukhles H.;
RT   "Synaptic localization of neuroligin 2 in the rodent retina: comparative
RT   study with the dystroglycan-containing complex.";
RL   J. Neurosci. Res. 88:837-849(2010).
RN   [10]
RP   INTERACTION WITH NRXN1.
RX   PubMed=20624592; DOI=10.1016/j.neuron.2010.06.001;
RA   Koehnke J., Katsamba P.S., Ahlsen G., Bahna F., Vendome J., Honig B.,
RA   Shapiro L., Jin X.;
RT   "Splice form dependence of beta-neurexin/neuroligin binding interactions.";
RL   Neuron 67:61-74(2010).
RN   [11]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=19914352; DOI=10.1016/j.neuroscience.2009.11.016;
RA   Levinson J.N., Li R., Kang R., Moukhles H., El-Husseini A., Bamji S.X.;
RT   "Postsynaptic scaffolding molecules modulate the localization of
RT   neuroligins.";
RL   Neuroscience 165:782-793(2010).
RN   [12]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22528485; DOI=10.1074/jbc.m111.280537;
RA   Suckow A.T., Zhang C., Egodage S., Comoletti D., Taylor P., Miller M.T.,
RA   Sweet I.R., Chessler S.D.;
RT   "Transcellular neuroligin-2 interactions enhance insulin secretion and are
RT   integral to pancreatic beta-cell function.";
RL   J. Biol. Chem. 287:19816-19826(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-714, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [14] {ECO:0000305}
RP   IDENTIFICATION IN A COMPLEX WITH MAGI2 AND IGSF9B.
RX   PubMed=23751499; DOI=10.1083/jcb.201209132;
RA   Woo J., Kwon S.K., Nam J., Choi S., Takahashi H., Krueger D., Park J.,
RA   Lee Y., Bae J.Y., Lee D., Ko J., Kim H., Kim M.H., Bae Y.C., Chang S.,
RA   Craig A.M., Kim E.;
RT   "The adhesion protein IgSF9b is coupled to neuroligin 2 via S-SCAM to
RT   promote inhibitory synapse development.";
RL   J. Cell Biol. 201:929-944(2013).
RN   [15]
RP   INTERACTION WITH MDGA1 AND MDGA2.
RX   PubMed=23248271; DOI=10.1073/pnas.1219987110;
RA   Lee K., Kim Y., Lee S.-J., Qiang Y., Lee D., Lee H.W., Kim H., Je H.S.,
RA   Suedhof T.C., Ko J.;
RT   "MDGAs interact selectively with neuroligin-2 but not other neuroligins to
RT   regulate inhibitory synapse development.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:336-341(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY, IDENTIFICATION IN A COMPLEX WITH
RP   LHFPL4; GABRA1; GABRB2; GABRG2 AND GABRB3, AND INTERACTION WITH LHFPL4 AND
RP   GABRA1.
RX   PubMed=28279354; DOI=10.1016/j.neuron.2017.02.023;
RA   Yamasaki T., Hoyos-Ramirez E., Martenson J.S., Morimoto-Tomita M.,
RA   Tomita S.;
RT   "GARLH family proteins stabilize GABAA receptors at synapses.";
RL   Neuron 93:1138-1152(2017).
RN   [17]
RP   SUBCELLULAR LOCATION.
RX   PubMed=29742426; DOI=10.1016/j.celrep.2018.04.015;
RA   Wu M., Tian H.L., Liu X., Lai J.H.C., Du S., Xia J.;
RT   "Impairment of inhibitory synapse formation and motor behavior in mice
RT   lacking the NL2 binding partner LHFPL4/GARLH4.";
RL   Cell Rep. 23:1691-1705(2018).
CC   -!- FUNCTION: Transmembrane scaffolding protein involved in cell-cell
CC       interactions via its interactions with neurexin family members.
CC       Mediates cell-cell interactions both in neurons and in other types of
CC       cells, such as Langerhans beta cells. Plays a role in synapse function
CC       and synaptic signal transmission, especially via gamma-aminobutyric
CC       acid receptors (GABA(A) receptors). Functions by recruiting and
CC       clustering synaptic proteins. Promotes clustering of postsynaptic
CC       GABRG2 and GPHN. Promotes clustering of postsynaptic LHFPL4 (By
CC       similarity). Modulates signaling by inhibitory synapses, and thereby
CC       plays a role in controlling the ratio of signaling by excitatory and
CC       inhibitory synapses and information processing. Required for normal
CC       signal amplitude from inhibitory synapses, but is not essential for
CC       normal signal frequency. May promote the initial formation of synapses,
CC       but is not essential for this. In vitro, triggers the de novo formation
CC       of presynaptic structures. Mediates cell-cell interactions between
CC       Langerhans beta cells and modulates insulin secretion.
CC       {ECO:0000250|UniProtKB:Q69ZK9, ECO:0000269|PubMed:19755106,
CC       ECO:0000269|PubMed:22528485}.
CC   -!- SUBUNIT: Interacts with neurexins NRXN1, NRXN2 and NRXN3
CC       (PubMed:18334216, PubMed:20624592, PubMed:8576240). Interaction with
CC       neurexins is mediated by heparan sulfate glycan modification on
CC       neurexin (By similarity). Interacts (via its C-terminus) with DLG4/PSD-
CC       95 (via PDZ domain 3) (By similarity). Interacts with PATJ
CC       (PubMed:9647694). Interacts with GPHN (PubMed:19755106). Interacts with
CC       MDGA1 and MDGA2 (PubMed:23248271). Found in a complex with MAGI2 and
CC       IGSF9B, where it interacts with MAGI2 (via WW 1, WW 2 and PDZ 2
CC       domains) (PubMed:23751499). Identified in a complex of 720 kDa composed
CC       of LHFPL4, NLGN2, GABRA1, GABRB2, GABRG2 and GABRB3 (PubMed:28279354).
CC       Interacts with LHFPL4; leading to mutual regulation of the protein
CC       level and synaptic clustering (PubMed:28279354, PubMed:29742426).
CC       Interacts with GABRA1 (PubMed:28279354). {ECO:0000250|UniProtKB:Q69ZK9,
CC       ECO:0000250|UniProtKB:Q8NFZ4, ECO:0000269|PubMed:18334216,
CC       ECO:0000269|PubMed:19755106, ECO:0000269|PubMed:20624592,
CC       ECO:0000269|PubMed:23248271, ECO:0000269|PubMed:23751499,
CC       ECO:0000269|PubMed:28279354, ECO:0000269|PubMed:29742426,
CC       ECO:0000269|PubMed:8576240, ECO:0000269|PubMed:9647694}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Postsynaptic cell membrane {ECO:0000269|PubMed:29742426}.
CC       Presynaptic cell membrane. Note=Detected at presynaptic membranes in
CC       retina, and at postsynaptic membranes in brain. Detected at dendritic
CC       spines in cultured neurons. Colocalizes with GPHN and ARHGEF9 at
CC       neuronal cell membranes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q62888-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q62888-2; Sequence=VSP_007533;
CC   -!- TISSUE SPECIFICITY: Detected on hippocampus neurons, especially at
CC       inhibitory synapses. Detected in retina, in the outer and inner
CC       plexiform layer. Detected in pancreas, in islet of Langerhans beta
CC       cells (at protein level). Expressed in brain, spinal cord and dorsal
CC       root ganglion. Detected in brain, and at lower levels in pancreas islet
CC       beta cells. {ECO:0000269|PubMed:11329178, ECO:0000269|PubMed:15620359,
CC       ECO:0000269|PubMed:18755801, ECO:0000269|PubMed:19755106,
CC       ECO:0000269|PubMed:19859968, ECO:0000269|PubMed:19914352,
CC       ECO:0000269|PubMed:8576240}.
CC   -!- SIMILARITY: Belongs to the type-B carboxylesterase/lipase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U41662; AAA97870.1; -; mRNA.
DR   RefSeq; NP_446444.1; NM_053992.1. [Q62888-1]
DR   PDB; 5V5V; X-ray; 4.11 A; A/B/C/D/E/F=42-612.
DR   PDBsum; 5V5V; -.
DR   AlphaFoldDB; Q62888; -.
DR   SMR; Q62888; -.
DR   BioGRID; 250669; 13.
DR   CORUM; Q62888; -.
DR   IntAct; Q62888; 5.
DR   MINT; Q62888; -.
DR   STRING; 10116.ENSRNOP00000075845; -.
DR   ESTHER; ratno-2neur; Neuroligin.
DR   MEROPS; S09.995; -.
DR   GlyCosmos; Q62888; 3 sites, No reported glycans.
DR   GlyGen; Q62888; 3 sites.
DR   iPTMnet; Q62888; -.
DR   PhosphoSitePlus; Q62888; -.
DR   PaxDb; 10116-ENSRNOP00000053713; -.
DR   ABCD; Q62888; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000056872.6; ENSRNOP00000053713.5; ENSRNOG00000015430.10. [Q62888-1]
DR   Ensembl; ENSRNOT00000092662.2; ENSRNOP00000075845.2; ENSRNOG00000015430.10. [Q62888-2]
DR   Ensembl; ENSRNOT00055050677; ENSRNOP00055041754; ENSRNOG00055029231. [Q62888-1]
DR   Ensembl; ENSRNOT00060054407; ENSRNOP00060045057; ENSRNOG00060031366. [Q62888-1]
DR   Ensembl; ENSRNOT00065051371; ENSRNOP00065042307; ENSRNOG00065029740. [Q62888-1]
DR   GeneID; 117096; -.
DR   KEGG; rno:117096; -.
DR   UCSC; RGD:621118; rat. [Q62888-1]
DR   AGR; RGD:621118; -.
DR   CTD; 57555; -.
DR   RGD; 621118; Nlgn2.
DR   eggNOG; KOG1516; Eukaryota.
DR   GeneTree; ENSGT00940000160598; -.
DR   InParanoid; Q62888; -.
DR   OMA; WADRDNT; -.
DR   OrthoDB; 4386at2759; -.
DR   PhylomeDB; Q62888; -.
DR   Reactome; R-RNO-6794361; Neurexins and neuroligins.
DR   PRO; PR:Q62888; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0043198; C:dendritic shaft; IDA:RGD.
DR   GO; GO:0098691; C:dopaminergic synapse; ISO:RGD.
DR   GO; GO:0060076; C:excitatory synapse; IDA:RGD.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0098690; C:glycinergic synapse; ISO:RGD.
DR   GO; GO:0060077; C:inhibitory synapse; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:BHF-UCL.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0097470; C:ribbon synapse; IDA:RGD.
DR   GO; GO:0045202; C:synapse; ISS:BHF-UCL.
DR   GO; GO:0050839; F:cell adhesion molecule binding; ISS:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0042043; F:neurexin family protein binding; ISS:BHF-UCL.
DR   GO; GO:0038023; F:signaling receptor activity; IBA:GO_Central.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0097116; P:gephyrin clustering involved in postsynaptic density assembly; ISS:BHF-UCL.
DR   GO; GO:1904862; P:inhibitory synapse assembly; ISO:RGD.
DR   GO; GO:1901142; P:insulin metabolic process; IDA:RGD.
DR   GO; GO:0007630; P:jump response; IMP:BHF-UCL.
DR   GO; GO:0035641; P:locomotory exploration behavior; ISS:BHF-UCL.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISS:BHF-UCL.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; ISS:BHF-UCL.
DR   GO; GO:0007158; P:neuron cell-cell adhesion; IDA:BHF-UCL.
DR   GO; GO:0072578; P:neurotransmitter-gated ion channel clustering; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IDA:RGD.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; IMP:RGD.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; ISS:BHF-UCL.
DR   GO; GO:0097151; P:positive regulation of inhibitory postsynaptic potential; IMP:BHF-UCL.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IDA:RGD.
DR   GO; GO:1902474; P:positive regulation of protein localization to synapse; IMP:RGD.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; IDA:BHF-UCL.
DR   GO; GO:0032230; P:positive regulation of synaptic transmission, GABAergic; ISS:BHF-UCL.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; ISS:BHF-UCL.
DR   GO; GO:2000809; P:positive regulation of synaptic vesicle clustering; ISO:RGD.
DR   GO; GO:1904034; P:positive regulation of t-SNARE clustering; IDA:RGD.
DR   GO; GO:0097119; P:postsynaptic density protein 95 clustering; ISS:BHF-UCL.
DR   GO; GO:0097104; P:postsynaptic membrane assembly; ISS:BHF-UCL.
DR   GO; GO:0098698; P:postsynaptic specialization assembly; ISO:RGD.
DR   GO; GO:0099054; P:presynapse assembly; ISO:RGD.
DR   GO; GO:0097105; P:presynaptic membrane assembly; IDA:BHF-UCL.
DR   GO; GO:0034394; P:protein localization to cell surface; ISO:RGD.
DR   GO; GO:0035418; P:protein localization to synapse; ISS:BHF-UCL.
DR   GO; GO:2000311; P:regulation of AMPA receptor activity; ISS:BHF-UCL.
DR   GO; GO:1905606; P:regulation of presynapse assembly; IDA:SynGO.
DR   GO; GO:0002087; P:regulation of respiratory gaseous exchange by nervous system process; ISS:BHF-UCL.
DR   GO; GO:0019233; P:sensory perception of pain; ISS:BHF-UCL.
DR   GO; GO:0035176; P:social behavior; IMP:BHF-UCL.
DR   GO; GO:0007416; P:synapse assembly; IDA:BHF-UCL.
DR   GO; GO:0050808; P:synapse organization; IDA:MGI.
DR   GO; GO:0051932; P:synaptic transmission, GABAergic; ISO:RGD.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; IBA:GO_Central.
DR   GO; GO:0072553; P:terminal button organization; IMP:BHF-UCL.
DR   GO; GO:0001966; P:thigmotaxis; IMP:BHF-UCL.
DR   Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR002018; CarbesteraseB.
DR   InterPro; IPR019819; Carboxylesterase_B_CS.
DR   InterPro; IPR051093; Neuroligin/BSAL.
DR   InterPro; IPR000460; Nlgn.
DR   PANTHER; PTHR43903; NEUROLIGIN; 1.
DR   PANTHER; PTHR43903:SF3; NEUROLIGIN-2; 1.
DR   Pfam; PF00135; COesterase; 1.
DR   PRINTS; PR01090; NEUROLIGIN.
DR   SUPFAM; SSF53474; alpha/beta-Hydrolases; 1.
DR   PROSITE; PS00941; CARBOXYLESTERASE_B_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell membrane;
KW   Cell projection; Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Membrane; Phosphoprotein; Postsynaptic cell membrane; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..14
FT                   /evidence="ECO:0000305|PubMed:8576240"
FT   CHAIN           15..836
FT                   /note="Neuroligin-2"
FT                   /id="PRO_0000008644"
FT   TOPO_DOM        15..678
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        679..699
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        700..836
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          623..661
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          679..699
FT                   /note="Required for interaction with LHFPL4"
FT                   /evidence="ECO:0000250|UniProtKB:Q69ZK9"
FT   REGION          711..735
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          791..836
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        627..653
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        793..823
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         714
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         719
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q69ZK9"
FT   CARBOHYD        98
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        136
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        522
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        106..141
FT                   /evidence="ECO:0000250"
FT   DISULFID        317..328
FT                   /evidence="ECO:0000250"
FT   DISULFID        487..521
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         153..169
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:8576240"
FT                   /id="VSP_007533"
FT   MUTAGEN         770
FT                   /note="Y->A: Abolishes interaction with GPHN."
FT                   /evidence="ECO:0000269|PubMed:19755106"
SQ   SEQUENCE   836 AA;  90961 MW;  1AD51CB1BE4BF9CF CRC64;
     MWLLALCLVG LAGAQRGGGG PGGGAPGGPG LGLGSLGEER FPVVNTAYGR VRGVRRELNN
     EILGPVVQFL GVPYATPPLG ARRFQPPEAP ASWPGVRNAT TLPPACPQNL HGALPAIMLP
     VWFTDNLEAA ATYVQNQSED CLYLNLYVPT EDGPLTKKRD EATLNPPDTD IRDSGKKPVM
     LFLHGGSYME GTGNMFDGSV LAAYGNVIVA TLNYRLGVLG FLSTGDQAAK GNYGLLDQIQ
     ALRWLSENIA HFGGDPERIT IFGSGAGASC VNLLILSHHS EGLFQKAIAQ SGTAISSWSV
     NYQPLKYTRL LAAKVGCDRE DSTEAVECLR RKSSRELVDQ DVQPARYHIA FGPVVDGDVV
     PDDPEILMQQ GEFLNYDMLI GVNQGEGLKF VEDSAESEDG VSASAFDFTV SNFVDNLYGY
     PEGKDVLRET IKFMYTDWAD RDNGEMRRKT LLALFTDHQW VAPAVATAKL HADYQSPVYF
     YTFYHHCQAE GRPEWADAAH GDELPYVFGV PMVGATDLFP CNFSKNDVML SAVVMTYWTN
     FAKTGDPNQP VPQDTKFIHT KPNRFEEVVW SKFNSKEKQY LHIGLKPRVR DNYRANKVAF
     WLELVPHLHN LHTELFTTTT RLPPYATRWP PRTPGPGTSG TRRPPPPATL PPESDIDLGP
     RAYDRFPGDS RDYSTELSVT VAVGASLLFL NILAFAALYY KRDRRQELRC RRLSPPGGSG
     SGVPGGGPLL PTAGRELPPE EELVSLQLKR GGGVGADPAE ALRPACPPDY TLALRRAPDD
     VPLLAPGALT LLPSGLGPPP PPPPPSLHPF GPFPPPPPTA TSHNNTLPHP HSTTRV
//
